Iron acetyltransferrin


Concise Prescribing Info
Indications/Uses
Fe-deficiency anaemia.
Dosage/Direction for Use
Adult : PO As elemental Fe: 100-200 mg/day in divided doses. Usual prophylactic dose: 60-120 mg/day.
Dosage Details
Oral
Iron-deficiency anaemia
Adult: As elemental iron: 100-200 mg daily in divided doses. Usual prophylactic dose: 60-120 mg daily.
Contraindications
Patients receiving repeated blood transfusions. Oral and parenteral iron therapy should not be used together.
Special Precautions
Haemochromatosis, haemoglobinopathies; existing GI diseases eg. inflammatory bowel disease, intestinal strictures and diverticulae.
Adverse Reactions
GI irritation and abdominal pain w/ nausea, vomiting, diarrhoea or constipation.
Drug Interactions
Compounds containing calcium and magnesium (including antacids and mineral supplements), bicarbonates, carbonates, oxalates, or phosphates, may impair the absorption of iron. Response to iron may be delayed when used w/ systemic chloramphenicol. Iron may decrease absorption of cefdinir, biphosphonates, entacapone, fluoroquinolones, levodopa, methyldopa, mycophenolate mofetil, penicillamine, levothyroxine. Absorption of both agents may be diminished when iron is taken with zinc salts, tetracyclines (separate admin by 2-3 hr), acetohydroxamic acid.
Potentially Fatal: Toxic complexes may form with dimercaprol.
Action
Description: Iron and iron salts are used for the treatment or prophylaxis of iron-deficiency anaemias. They should not be given for the treatment of other types of anaemia except where iron deficiency is also present. Iron-deficiency anaemias respond readily to iron therapy but the underlying cause of the anaemia should be determined and treated.
Disclaimer: This information is independently developed by MIMS based on Iron acetyltransferrin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in